Last Updated on September 30, 2024 by The Health Master

Ketamine

Ketamine, a well-known anaesthetic and analgesic drug, has garnered attention not only for its medical applications but also for its classification under regulatory frameworks.

Understanding Ketamine’s Classification

The Categorization Process

• Ketamine’s classification as a psychotropic substance was formalized through notification no. S.O. 311(E) dated 10.02.2011, issued by the Department of Revenue, Ministry of Finance, Government of India.
• Ketamine also classifies as small quantity (10gm) and commercial quantity (500gm) under NDPS Act 1985 vide notification No. S.O. 1430(E) dated 21.06.2011 issued by the Department of Revenue, Ministry of Finance, Government of India.

Scheduled X Drug Declaration:

• Further, it was declared as a Scheduled X drug under notification no. GSR 724(E) dated 07.11.2013, issued by the Department of Health, Ministry of Health and Family Welfare, Government of India.

Regulatory Requirements for Ketamine

Mandatory Label Warnings

Labelling Mandates

• Both warnings for psychotropic substances and Scheduled X drugs are obligatory to be printed on the label of ketamine.
• NRx should be printed in red colour on the top left corner on the label.

Licensing Regulations

Necessity of Separate License

• Manufacturing and sale of ketamine drug require a separate license under Schedule X, as mandated by regulatory authorities.
• Ketamine is not Essential Narcotics Drugs (END) for the purpose of Recognized Medical Institute (RMI).

Compliance and Enforcement

Ensuring Adherence to Regulations

Regulatory Oversight

• Regulatory bodies enforce stringent measures to ensure compliance with labelling requirements and licensing regulations for ketamine

Monitoring Supply Chains

• Inspection and monitoring of supply chains are conducted to verify adherence to regulatory mandates concerning ketamine

For informative videos by The Health Master, click on the below YouTube icon:

• Delhi High Court grants Injunction in ‘Biochem’ Trademark dispute
  November 15, 2024
• Beyond the Pill: DCGI Pushes for Diversified Pharma Education
  November 15, 2024
• DCGI and Cosmetics Industry to meet on Regulatory issues
  November 14, 2024
• Significance of Granules Manufacturing in the Pharmaceutical Industry
  November 14, 2024
• 4th International Conference on Pharmaceutical and Healthcare: Lloyd
  November 13, 2024
• USFDA approval granted for Medical Device for heart condition
  November 13, 2024

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

For informative videos on consumer awareness, click on the below YouTube icon: